Bionomics is a clinical-stage biopharmaceutical company developing a pipeline of novel, ion channel targeting drug candidates designed to transform the lives of patients suffering from serious Central Nervous System (“CNS”) disorders.
Bionomics (BNOX) is a company based in Eastwood, South Australia, that operates in the biomedical engineering industry. The organization is also involved in the broader field of engineering. Bionomics is currently listed on the Nasdaq stock exchange and operates in the country of Australia.
The company has been granted 49 patents to date.
Small Molecules
Bionomics is a clinical-stage biopharmaceutical company developing a pipeline of novel, ion channel targeting drug candidates designed to transform the lives of patients suffering from serious Central Nervous System (“CNS”) disorders.
Bionomics is a clinical-stage biopharmaceutical company developing a pipeline of novel, ion channel targeting drug candidates designed to transform the lives of patients suffering from serious Central Nervous System (“CNS”) disorders.